Jalpeshkumar Bhavsar: Formulation and In Vitro Evaluation of Buccal Tablet of Famotidine - Pasta blanda
ISBN: 9783659137501
The formulation with deduction of acid secretion Famotidine is histamine H2 receptor antagonist. It has bioavailability of 40 to 45% and it has shorter plasma half life of 2.5 to 3.5 hrs.… Más…
The formulation with deduction of acid secretion Famotidine is histamine H2 receptor antagonist. It has bioavailability of 40 to 45% and it has shorter plasma half life of 2.5 to 3.5 hrs. The effective treatment of erosive esophagitis and Zolinger-Elisons syndrome requires administration of 20 mg of Famotidine 4 times a day. A conventional dose of 20 mg can inhibit gastric acid secretion up to 5 hours but not up to 10 hours. An alternative dose of 40 mg leads to plasma fluctuations thus a sustained release dosage form of famotidine is desirable. Direct access to the systemic circulation bypasses drugs from the hepatic first pass metabolism leading to high bioavailability. Moreover, the buccal route is easily accessible, has a good patient compliance and can be used in patients who can t swallow. Bilayer buccal tablet was prepared by using mucoadhesive polymer combination of Sodium CMC and Carbopol934P, by direct compression with backing layer of Ethyl cellulose. The optimized formulation F1 had given release of 102.57% in 8hrs and it had optimum swelling, mucoadhesive property and permeation from buccal mucosa. It also had desired drug release kinetics and found to be stable for the period of 1 month. Formulation and In Vitro Evaluation of Buccal Tablet of Famotidine: Famotidine is histamine H2 receptor antagonist. It has bioavailability of 40 to 45% and it has shorter plasma half life of 2.5 to 3.5 hrs. The effective treatment of erosive esophagitis and Zolinger-Elisons syndrome requires administration of 20 mg of Famotidine 4 times a day. A conventional dose of 20 mg can inhibit gastric acid secretion up to 5 hours but not up to 10 hours. An alternative dose of 40 mg leads to plasma fluctuations thus a sustained release dosage form of famotidine is desirable. Direct access to the systemic circulation bypasses drugs from the hepatic first pass metabolism leading to high bioavailability. Moreover, the buccal route is easily accessible, has a good patient compliance and can be used in patients who can t swallow. Bilayer buccal tablet was prepared by using mucoadhesive polymer combination of Sodium CMC and Carbopol934P, by direct compression with backing layer of Ethyl cellulose. The optimized formulation F1 had given release of 102.57% in 8hrs and it had optimum swelling, mucoadhesive property and permeation from buccal mucosa. It also had desired drug release kinetics and found to be stable for the period of 1 month., LAP Lambert Academic Publishing<
Rheinberg-Buch.de
Taschenbuch, Englisch, Neuware Gastos de envío:Ab 20¤ Versandkostenfrei in Deutschland, Print on Demand, DE. (EUR 0.00) Details...
(*) Libro agotado significa que este título no está disponible por el momento en alguna de las plataformas asociadas que buscamos.
Jalpeshkumar Bhavsar: Formulation and In Vitro Evaluation of Buccal Tablet of Famotidine - libro nuevo
ISBN: 9783659137501
Famotidine is histamine H2 receptor antagonist. It has bioavailability of 40 to 45% and it has shorter plasma half life of 2.5 to 3.5 hrs. The effective treatment of erosive esophagitis a… Más…
Famotidine is histamine H2 receptor antagonist. It has bioavailability of 40 to 45% and it has shorter plasma half life of 2.5 to 3.5 hrs. The effective treatment of erosive esophagitis and Zolinger-Elisons syndrome requires administration of 20 mg of Famotidine 4 times a day. A conventional dose of 20 mg can inhibit gastric acid secretion up to 5 hours but not up to 10 hours. An alternative dose of 40 mg leads to plasma fluctuations; thus a sustained release dosage form of famotidine is desirable. Direct access to the systemic circulation bypasses drugs from the hepatic first pass metabolism leading to high bioavailability. Moreover, the buccal route is easily accessible, has a good patient compliance and can be used in patients who can t swallow. Bilayer buccal tablet was prepared by using mucoadhesive polymer combination of Sodium CMC and Carbopol934P, by direct compression with backing layer of Ethyl cellulose. The optimized formulation F1 had given release of 102.57% in 8hrs and it had optimum swelling, mucoadhesive property and permeation from buccal mucosa. It also had desired drug release kinetics and found to be stable for the period of 1 month. Bücher / Naturwissenschaften, Medizin, Informatik & Technik / Medizin / Pharmazie<
Dodax.de
Nr. 57d16b414e9492092afdbbcc Gastos de envío:Versandkosten: 0.0 EUR, Lieferzeit: 5 Tage, DE. (EUR 0.00) Details...
(*) Libro agotado significa que este título no está disponible por el momento en alguna de las plataformas asociadas que buscamos.
Jalpeshkumar Bhavsar, Mukesh Patel, Natvarlal Patel: Formulation and In Vitro Evaluation of Buccal Tablet of Famotidine als Buch von Jalpeshkumar Bhavsar, Mukesh Patel, Natvarlal Patel - encuadernado, tapa blanda
ISBN: 9783659137501
Formulation and In Vitro Evaluation of Buccal Tablet of Famotidine:The formulation with deduction of acid secretion Jalpeshkumar Bhavsar, Mukesh Patel, Natvarlal Patel Formulation and In … Más…
Formulation and In Vitro Evaluation of Buccal Tablet of Famotidine:The formulation with deduction of acid secretion Jalpeshkumar Bhavsar, Mukesh Patel, Natvarlal Patel Formulation and In Vitro Evaluation of Buccal Tablet of Famotidine:The formulation with deduction of acid secretion Jalpeshkumar Bhavsar, Mukesh Patel, Natvarlal Patel Bücher > Wissenschaft > Medizin, LAP Lambert Academic Publishing<
Hugendubel.de
No. 19138031 Gastos de envío:, , DE (EUR 0.00) Details...
(*) Libro agotado significa que este título no está disponible por el momento en alguna de las plataformas asociadas que buscamos.
Jalpeshkumar Bhavsar, Mukesh Patel, Natvarlal Patel: Formulation and In Vitro Evaluation of Buccal Tablet of Famotidine als Buch von Jalpeshkumar Bhavsar, Mukesh Patel, Natvarlal Patel - encuadernado, tapa blanda
ISBN: 9783659137501
Lieferung innerhalb 1-4 Werktagen. Versandkostenfrei, wenn Buch oder Hörbuch enthalten ist, sonst 2,95 EUR. Ab 19,90 EUR versandkostenfrei. (Deutschland) Bücher > Wissenschaft > Mediz… Más…
Lieferung innerhalb 1-4 Werktagen. Versandkostenfrei, wenn Buch oder Hörbuch enthalten ist, sonst 2,95 EUR. Ab 19,90 EUR versandkostenfrei. (Deutschland) Bücher > Wissenschaft > Medizin, LAP Lambert Academic Publishing<
Hugendubel.de
No. 19138031. Gastos de envío:Zzgl. Versandkosten. (EUR 0.00) Details...
(*) Libro agotado significa que este título no está disponible por el momento en alguna de las plataformas asociadas que buscamos.
Formulation and In Vitro Evaluation of Buccal Tablet of Famotidine - Pasta blanda
ISBN: 9783659137501
The formulation with deduction of acid secretion Famotidine is histamine H2 receptor antagonist. It has bioavailability of 40 to 45% and it has shorter plasma half life of 2.5 to 3.5 hrs.… Más…
The formulation with deduction of acid secretion Famotidine is histamine H2 receptor antagonist. It has bioavailability of 40 to 45% and it has shorter plasma half life of 2.5 to 3.5 hrs. The effective treatment of erosive esophagitis and Zolinger-Elisons syndrome requires administration of 20 mg of Famotidine 4 times a day. A conventional dose of 20 mg can inhibit gastric acid secretion up to 5 hours but not up to 10 hours. An alternative dose of 40 mg leads to plasma fluctuations thus a sustained release dosage form of famotidine is desirable. Direct access to the systemic circulation bypasses drugs from the hepatic first pass metabolism leading to high bioavailability. Moreover, the buccal route is easily accessible, has a good patient compliance and can be used in patients who can t swallow. Bilayer buccal tablet was prepared by using mucoadhesive polymer combination of Sodium CMC and Carbopol934P, by direct compression with backing layer of Ethyl cellulose. The optimized formulation F1 had given release of 102.57% in 8hrs and it had optimum swelling, mucoadhesive property and permeation from buccal mucosa. It also had desired drug release kinetics and found to be stable for the period of 1 month. Formulation and In Vitro Evaluation of Buccal Tablet of Famotidine: Famotidine is histamine H2 receptor antagonist. It has bioavailability of 40 to 45% and it has shorter plasma half life of 2.5 to 3.5 hrs. The effective treatment of erosive esophagitis and Zolinger-Elisons syndrome requires administration of 20 mg of Famotidine 4 times a day. A conventional dose of 20 mg can inhibit gastric acid secretion up to 5 hours but not up to 10 hours. An alternative dose of 40 mg leads to plasma fluctuations thus a sustained release dosage form of famotidine is desirable. Direct access to the systemic circulation bypasses drugs from the hepatic first pass metabolism leading to high bioavailability. Moreover, the buccal route is easily accessible, has a good patient compliance and can be used in patients who can t swallow. Bilayer buccal tablet was prepared by using mucoadhesive polymer combination of Sodium CMC and Carbopol934P, by direct compression with backing layer of Ethyl cellulose. The optimized formulation F1 had given release of 102.57% in 8hrs and it had optimum swelling, mucoadhesive property and permeation from buccal mucosa. It also had desired drug release kinetics and found to be stable for the period of 1 month., LAP Lambert Academic Publishing<
- Taschenbuch, Englisch, Neuware Gastos de envío:Ab 20¤ Versandkostenfrei in Deutschland, Print on Demand, DE. (EUR 0.00)
Formulation and In Vitro Evaluation of Buccal Tablet of Famotidine - libro nuevo
ISBN: 9783659137501
Famotidine is histamine H2 receptor antagonist. It has bioavailability of 40 to 45% and it has shorter plasma half life of 2.5 to 3.5 hrs. The effective treatment of erosive esophagitis a… Más…
Famotidine is histamine H2 receptor antagonist. It has bioavailability of 40 to 45% and it has shorter plasma half life of 2.5 to 3.5 hrs. The effective treatment of erosive esophagitis and Zolinger-Elisons syndrome requires administration of 20 mg of Famotidine 4 times a day. A conventional dose of 20 mg can inhibit gastric acid secretion up to 5 hours but not up to 10 hours. An alternative dose of 40 mg leads to plasma fluctuations; thus a sustained release dosage form of famotidine is desirable. Direct access to the systemic circulation bypasses drugs from the hepatic first pass metabolism leading to high bioavailability. Moreover, the buccal route is easily accessible, has a good patient compliance and can be used in patients who can t swallow. Bilayer buccal tablet was prepared by using mucoadhesive polymer combination of Sodium CMC and Carbopol934P, by direct compression with backing layer of Ethyl cellulose. The optimized formulation F1 had given release of 102.57% in 8hrs and it had optimum swelling, mucoadhesive property and permeation from buccal mucosa. It also had desired drug release kinetics and found to be stable for the period of 1 month. Bücher / Naturwissenschaften, Medizin, Informatik & Technik / Medizin / Pharmazie<
- Nr. 57d16b414e9492092afdbbcc Gastos de envío:Versandkosten: 0.0 EUR, Lieferzeit: 5 Tage, DE. (EUR 0.00)
Jalpeshkumar Bhavsar, Mukesh Patel, Natvarlal Patel: Formulation and In Vitro Evaluation of Buccal Tablet of Famotidine als Buch von Jalpeshkumar Bhavsar, Mukesh Patel, Natvarlal Patel - encuadernado, tapa blanda
ISBN: 9783659137501
Formulation and In Vitro Evaluation of Buccal Tablet of Famotidine:The formulation with deduction of acid secretion Jalpeshkumar Bhavsar, Mukesh Patel, Natvarlal Patel Formulation and In … Más…
Formulation and In Vitro Evaluation of Buccal Tablet of Famotidine:The formulation with deduction of acid secretion Jalpeshkumar Bhavsar, Mukesh Patel, Natvarlal Patel Formulation and In Vitro Evaluation of Buccal Tablet of Famotidine:The formulation with deduction of acid secretion Jalpeshkumar Bhavsar, Mukesh Patel, Natvarlal Patel Bücher > Wissenschaft > Medizin, LAP Lambert Academic Publishing<
Jalpeshkumar Bhavsar, Mukesh Patel, Natvarlal Patel: Formulation and In Vitro Evaluation of Buccal Tablet of Famotidine als Buch von Jalpeshkumar Bhavsar, Mukesh Patel, Natvarlal Patel - encuadernado, tapa blanda
ISBN: 9783659137501
Lieferung innerhalb 1-4 Werktagen. Versandkostenfrei, wenn Buch oder Hörbuch enthalten ist, sonst 2,95 EUR. Ab 19,90 EUR versandkostenfrei. (Deutschland) Bücher > Wissenschaft > Mediz… Más…
Lieferung innerhalb 1-4 Werktagen. Versandkostenfrei, wenn Buch oder Hörbuch enthalten ist, sonst 2,95 EUR. Ab 19,90 EUR versandkostenfrei. (Deutschland) Bücher > Wissenschaft > Medizin, LAP Lambert Academic Publishing<
- No. 19138031. Gastos de envío:Zzgl. Versandkosten. (EUR 0.00)
1Dado que algunas plataformas no nos comunican las condiciones de envío y éstas pueden depender del país de entrega, del precio de compra, del peso y tamaño del artículo, de una posible membresía a la plataforma, de una entrega directa por parte de la plataforma o a través de un tercero (Marketplace), etc., es posible que los gastos de envío indicados por eurolibro/terralibro no concuerden con los de la plataforma ofertante.
Detalles del libro - Formulation and In Vitro Evaluation of Buccal Tablet of Famotidine
EAN (ISBN-13): 9783659137501 ISBN (ISBN-10): 3659137502 Tapa dura Tapa blanda Año de publicación: 2012 Editorial: LAP Lambert Academic Publishing
Libro en la base de datos desde 2009-02-18T14:22:14+01:00 (Madrid) Página de detalles modificada por última vez el 2018-03-16T07:34:25+01:00 (Madrid) ISBN/EAN: 3659137502
ISBN - escritura alterna: 3-659-13750-2, 978-3-659-13750-1 Mode alterno de escritura y términos de búsqueda relacionados: Título del libro: tablet, vitro